Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.20.4
Consolidated Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenue    
Total revenues $ 436,942 $ 17,066
Operating costs and expenses:    
Research and development (1,731,406) (4,889,340)
General and administrative (3,400,071) (4,731,176)
Asset impairment charges (Note 7) (9,243,128) (3,283,379)
Total operating costs and expenses (14,374,605) (12,903,895)
Loss from operations (13,937,663) (12,886,829)
Other income (expense):    
Other income (expense) (492) 3,315
Interest income, net 126,171 108,489
Total other income 125,679 111,804
Loss before income taxes (13,811,984) (12,775,025)
Income tax benefit 2,918,518 0
Net loss (10,893,466) (12,775,025)
Deemed dividend 0 (5,284,379)
Net loss applicable to common stockholders $ (10,893,466) $ (18,059,404)
Basic and diluted loss per share $ (1.70) $ (6.33)
Weighted-average shares of common stock outstanding, basic and diluted 6,392,381 2,852,464
Royalty [Member]    
Revenue    
Total revenues $ 436,942 $ 17,066